Armotraz 1 Mg
- Manufacturer : Cipla Ltd
- Equivalent Brands : Arimidex
- Generic Brands : Anastrozole
Armotraz 1 mg Tablet is used along with other therapies in the treatment of breast cancer in postmenopausal women. This medicine is also used to treat women whose breast cancer has worsened after tamoxifen therapy.
Armotraz tablets 1mg contain anastrozole, which is a potent and highly selective inhibitor of aromatase, an enzyme that is involved in the biosynthesis of the female hormone oestrogen.
In premenopausal women the primary source of oestrogen production are the ovaries and it is involved in producing secondary sexual characteristics, such as breast development and in regulating the menstrual cycle.
In postmenopausal women, when oestrogen production by the ovaries ceases, low levels of oestrogen are made in peripheral tissues, such as fat cells throughout the body, also some breast cancer cells, by conversion of androstenedione (produced by the adrenal glands) to estrone due to the action of aromatase and then by further conversion to oestradiol (the most active form of circulating oestrogen.
Many breast cancers have oestrogen receptors and their growth is stimulated by oestrogen; low levels of oestrogen may be sufficient to maintain growth of breast cancer cells in women with breast cancer.
Anastrozole in Armotraz tablets 1mg blocks the action of aromatase, preventing the formation of oestrogen and helping to prevent growth of oestrogen-dependent breast tumours.
You should take your Armotraz tablets 1mg with a glass of water once a day with or without food. You should continue taking your Armotraz tablets 1mg for as long as recommended by your doctor, but in early cases of breast cancer, for no longer than 5 years.
Armotraz tablets 1mg are to treat breast cancer in postmenopausal women. They contain anastrozole, which blocks the action of aromatase an enzyme involved in the biosynthesis of the female hormone oestrogen, in peripheral tissues, such as fat cells and also by some breast cancer cells. Many breast cancers have oestrogen receptors and their growth is stimulated by oestrogen; low levels of oestrogen may be sufficient to maintain growth of breast cancer cells in women with breast cancer. Anastrozole in Armotraz tablets 1mg blocks the action of aromatase, preventing the formation of oestrogen and helping to prevent growth of oestrogen-dependent breast tumours. Armotraz tablets 1mg are used as first-line therapy for early, advanced or metastatic breast cancer, also in conjunction with other breast cancer treatment (tamoxifen) or if tamoxifen therapy has not helped prevent progression of the tumour.
The most commonly reported side effects when taking Armotraz include:
If you have an allergy to anastrozole or any other part of this drug. Tell your doctor if you are allergic to any drugs. Make sure to tell about the allergy and what signs you had. This includes telling about rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you are pregnant or may be pregnant. If you have not stopped your period.
Armotraz tablets 1mg are used to treat breast cancer in postmenopausal women, as first line therapy for early, advanced or metastatic breast cancer. Armotraz tablets 1mg are also used as additional treatment for early breast cancer in conjunction with other breast cancer treatment (tamoxifen) or if tamoxifen therapy has not helped prevent progression of the tumour.
Store in a cool, dry place away from the reach of children. - Medicines must not be used past the expiry date.